-+ 0.00%
-+ 0.00%
-+ 0.00%

REVOLUTION MEDICINES, INC. : LEERINK PARTNERS RESUMES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $288

Reuters·10/05/2026 10:13:01